| (Values in U.S. Thousands) | Mar, 2026 | Dec, 2025 | Sep, 2025 | Jun, 2025 | Mar, 2025 |
| Sales | 3,758,020 | 3,623,220 | 3,396,130 | 3,274,720 | 3,402,080 |
| Sales Growth | +3.72% | +6.69% | +3.71% | -3.74% | +6.88% |
| Net Income | 270,440 | 562,420 | 307,320 | 589,950 | 571,640 |
| Net Income Growth | -51.91% | +83.01% | -47.91% | +3.20% | +40.60% |
Daiichi Sankyo ADR (DSNKY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Daiichi Sankyo Company Limited manufactures and sells pharmaceutical products principally in Japan, North America, Europe and internationally. Daiichi Sankyo Company Limited is based in Tokyo, Japan.
Fiscal Year End Date: 03/31